Firefly Neuroscience, Inc.
AIFF · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -78.3% | – | -100% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 38% | 100% | – | 100% |
| R&D Expenses | $2 | $1 | $1 | $3 |
| G&A Expenses | $6 | $2 | $2 | $2 |
| SG&A Expenses | $7 | $3 | $2 | $2 |
| Sales & Mktg Exp. | $1 | $1 | $0 | $0 |
| Other Operating Expenses | -$0 | $0 | $0 | $0 |
| Operating Expenses | $9 | $4 | $3 | $5 |
| Operating Income | -$9 | -$3 | -$3 | -$5 |
| % Margin | -8,500% | -618.1% | – | -14,543.8% |
| Other Income/Exp. Net | -$1 | $0 | -$0 | $0 |
| Pre-Tax Income | -$10 | -$3 | -$4 | -$4 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$10 | -$3 | -$4 | -$4 |
| % Margin | -9,685.2% | -522.7% | – | -13,690.6% |
| EPS | -1.6 | -0.33 | -0.48 | -0.56 |
| % Growth | -384.8% | 31.2% | 14.3% | – |
| EPS Diluted | -1.6 | -0.33 | -0.48 | -0.56 |
| Weighted Avg Shares Out | 7 | 8 | 8 | 8 |
| Weighted Avg Shares Out Dil | 7 | 8 | 8 | 8 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $1 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$10 | -$3 | -$3 | -$4 |
| % Margin | -9,557.4% | -518.9% | – | -11,928.1% |